A new study reports important differences between the characteristics of patients with end-stage renal disease on dialysis who are enrolled in clinical trials worldwide and the general US dialysis population. These findings highlight the importance of including older patients and those with comorbidities in clinical trials.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ioannisis, J. P. Why most published research findings are false. PLOS Med. 2, e124 (2005).
Guyatt, G. et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 64, 383–394 (2011).
Smyth, B. et al. Representativeness of randomised clinical trial cohorts in end-stage kidney disease. A meta-analysis. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed.2019.1501 (2019).
United States Renal Data System. Annual report 2018. Volume 2: End-Stage Renal Disease in the United States. 2018 ADR Reference Tables. USRDS https://www.usrds.org/reference.aspx (2018).
Lozier, M. R. et al. Comparison of cardiovascular outcomes by dialysis modality: a systematic review and meta-analysis. Perit. Dial. Int. 39, 306–314 (2019).
Stirnadel-Farrant, H. A. et al. Cardiovascular event rates among hemodialysis patients across geographical regions - a snapshot from the dialysis outcomes and practice patterns study (DOPPS). Kidney Int. Rep. 4, 864–872 (2019).
Iyasere, O. et al. Longitudinal trends in quality of life and physical function in frail older dialysis patients: a comparison of assisted peritoneal dialysis and in-center hemodialysis. Perit. Dial. Int. 39, 112–118 (2019).
Ioannisis, J. P. How to make more published research true. PLOS Med. 11, e1001747 (2014).
World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation 2011. WHO https://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/ (2011).
Peters, S. A. et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol. Dial. Transplant. 31, 978–984 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Davenport, A. Disparities between trial cohorts and real-life patients. Nat Rev Nephrol 15, 666–667 (2019). https://doi.org/10.1038/s41581-019-0202-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-019-0202-z
